Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas

被引:11
|
作者
Xu, Richard Huan [1 ,2 ]
Wong, Eliza Lai Yi [1 ,2 ]
Jin, Jun [3 ]
Dou, Ying [3 ]
Dong, Dong [1 ,2 ,4 ]
机构
[1] Chinese Univ Hong Kong, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Ctr Hlth Syst & Policy Res, Hong Kong, Peoples R China
[3] Tsinghua Univ, Sch Social Sci, Dept Sociol, Beijing, Peoples R China
[4] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China
来源
EUROPEAN JOURNAL OF HEALTH ECONOMICS | 2020年 / 21卷 / 09期
关键词
EORTC QLQ-C30; EQ-5D-5L; Mapping algorithm; Lymphoma; China; VARIABLE MIXTURE-MODELS; OF-LIFE INSTRUMENTS; EUROPEAN-ORGANIZATION; UTILITY VALUES; QUALITY; VALIDITY;
D O I
10.1007/s10198-020-01220-w
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objective The objective of this study was to develop algorithms to map the EORTC QLQ-C30 (QLQ-C30) onto EQ-5D-5L in a sample of patients with lymphomas. Methods An online nationwide survey of patients with lymphoma was carried out in China. Ordinary least squares (OLS), beta-based mixture, adjusted limited dependent variable mixture regression, and a Tobit regression model were used to develop the mapping algorithms. The QLQ-C30 subscales/items, their squared and interaction terms, and respondents' demographic variables were used as independent variables. The root mean square error (RMSE), mean absolute error (MAE), and R-squared (R-2) were estimated based on tenfold cross-validation to assess the predictive ability of the selected models. Results Data of 2222/4068 respondents who self-completed the online survey were elicited for analyses. The mean EQ-5D-5L index score was 0.81 (SD0.21, range - 0.81-1.0). 19.98% of respondents reported an index score at 1.0. In total, 72 models were generated based on four regression methods. According to the RMSE, MAE andR(2), the OLS model including QLQ-C30 subscales, squared terms, interaction terms, and demographic variables showed the best fit for overall and the Non-Hodgkin's lymphoma sample; for Hodgkin's lymphoma, the ALDVMM with 1-component model, including QLQ-C30 subscales, squared terms, interaction terms, and demographic variables, showed a better fit than the other models. Conclusion The mapping algorithms enable the EQ-5D-5L index scores to be predicted by QLQ-C30 subscale/item scores with good precision in patients living with lymphomas.
引用
收藏
页码:1363 / 1373
页数:11
相关论文
共 50 条
  • [21] Quality of Life of Cancer Patients during Chemotherapy in Indonesia: A Comparison of EORTC QLQ-C30 and EQ-5D-5L, Based on Patients' Characteristics
    Perwitasari, Dyah A. A.
    Purba, Fredrick D. D.
    Candradewi, Susan F. F.
    Dania, Haafizah
    Irham, Lalu Muhammad
    Faridah, Imaniar Noor
    Septiantoro, Bayu P. P.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2023, 2023
  • [22] UTILITY MAPPING OF THE EORTC QLQ-C30 ONTO EQ-5D IN PATIENTS WITH SOFT TISSUE SARCOMA
    Amdahl, J.
    Manson, S. C.
    Isbell, R.
    Chit, A.
    Delea, T. E.
    VALUE IN HEALTH, 2013, 16 (07) : A419 - A419
  • [23] Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer (vol 21, 1237, 2021)
    Gray, Laura A.
    Hernandez Alava, Monica
    Wailoo, Allan J.
    BMC CANCER, 2022, 22 (01)
  • [24] Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients
    Iftekhar Khan
    Steve Morris
    Nora Pashayan
    Bashir Matata
    Zahid Bashir
    Joe Maguirre
    Health and Quality of Life Outcomes, 14
  • [25] Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients
    Khan, Iftekhar
    Morris, Steve
    Pashayan, Nora
    Matata, Bashir
    Bashir, Zahid
    Maguirre, Joe
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2016, 14
  • [26] Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms
    Brett Doble
    Paula Lorgelly
    Quality of Life Research, 2016, 25 : 891 - 911
  • [27] Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms
    Doble, Brett
    Lorgelly, Paula
    QUALITY OF LIFE RESEARCH, 2016, 25 (04) : 891 - 911
  • [28] Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients
    Ameri, Hosein
    Yousefi, Mahmood
    Yaseri, Mehdi
    Nahvijou, Azin
    Arab, Mohammad
    Sari, Ali Akbari
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (01) : 89 - 96
  • [29] NAVIGATING INDIRECT UTILITY MODELS IN CANCER: MAPPING THE EORTC QLQ-C30 ONTO THE EQ-5D
    Doble, Brett
    Harris, Anthony
    Lorgelly, Paula
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 121 - 121
  • [30] Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D
    Admassu N. Lamu
    Jan Abel Olsen
    Quality of Life Research, 2018, 27 : 2823 - 2839